Abstract :
[en] Background/Objectives: Hypnosis shows great potential for managing patients suffering from fibromyalgia and chronic pain. Several studies have highlighted its efficacy in improving pain, quality of life, and reducing psychological distress. Despite its known feasibility and efficacy, the mechanisms of action remain poorly understood. Building on these insights, this innovative study aims to assess neural activity during hypnosis in fibromyalgia patients using high-density electroencephalography (EEG) and self-reported measures. Methods: Thirteen participants with fibromyalgia were included in this study. EEG recordings were done during resting state and hypnosis conditions. After both conditions, levels of pain, comfort, absorption, and dissociation were assessed using a numerical rating scale. Time perception was collected via an open-ended question. The study was prospectively registered in the ClinicalTrials.gov public registry (NCT04263324). Results: Neural oscillations showed increased theta power during hypnosis in the left parietal and occipital electrodes, increased beta power in the frontal and left temporal electrodes, and increased slow-gamma power in the frontal and left parietal electrodes. Functional connectivity using pairwise-phase consistency measures showed decreased connectivity in the frontal electrodes during hypnosis. Graph-based measures, the node strength, and the cluster coefficient were lower in frontal electrodes in the slow-gamma bands during hypnosis compared to resting state. Key findings indicate significant changes in neural oscillations and brain functional connectivity, suggesting potential electrophysiological markers of hypnosis in this patient population.
Funding text :
The study was supported by the University and University Hospital of Li\u00E8ge and its Algology Interdisciplinary Centre and its Fonds Internes pour la Recherche Scientifique (FIRS), the AstraZeneca foundation, the Belgium Foundation Against Cancer (grant nos. 2017064 and C/2020/1357), the Benoit Foundation, the Fonds National pour la Recherche Scientifique (FNRS), and the European Foundation of Biomedical Research (FERB) Onlus and Wallonia, as part of a 474 program of the BioWin Health Cluster framework. O.G. is a research associate at FNRS. S.L. is supported by the National Natural Science Foundation of China (grant no. 81920108023), the European Foundation of Biomedical Research (FERB) Onlus, the Fund Generet of the King Baudouin Foundation, and the Mind Care International Foundation. S.L. is Chairholder of the Canada Excellence Research Chair in Neuroplasticity, Laval University, the CERVO Brain Research Centre, Quebec, Canada, and Research Director at the National Fund for Scientific Research, Belgium.
Scopus citations®
without self-citations
2